For the second consecutive year, Cellomatics Biosciences has been selected as a regional winner in the annual Barclays Entrepreneur Awards and shortlisted as a finalist in the International Expansion Category.
Invited guests enjoyed a look around our new lab facilities at Colwick Quays Business Park last week, at a special launch event hosted by Cellomatics’ CEO and founder, Dr Shailendra
Dr Shailendra Singh, CEO and founder of Cellomatics Biosciences, attended a prestigious reception at Buckingham Palace yesterday (12 July 2022) to celebrate the company winning the Queen’s Award for Enterprise
Cellomatics recently worked on a project relating to Parkinson’s disease for a company in the biotech industry. Find out more in our case study below. Did this project relate to
We are delighted to announce that we have moved into new purpose-built premises in Nottingham in the wake of rising demand for our bespoke preclinical and early drug discovery phase
We’re delighted to announce that Cellomatics Biosciences has today been recognised with one of the UK’s most prestigious business awards – the Queen’s Award for Enterprise for International Trade. Cellomatics is one
Cellomatics will be attending Bio Integrates 2022 in-person on 17th May in London. The conference will be addressing the needs of innovative companies developing the therapies of tomorrow and proving
Cellomatics will be attending ‘Belgium Economic Mission: Belgium, The Health & Biotech Valley of Tomorrow by OBN’ on May 11th at St Hilda’s College in Oxford. The event will feature
Shailendra Singh will be attending the BioTrinity 2022 event on April 26-27th in London. BioTrinity is an established conference that supports in-person re-engagement across the life sciences industry. This year
Cellomatics has appointed Anand Krishna as senior director to oversee customer engagement and strategy and support its continued growth plans. Anand brings over 25 years of executive leadership and field
